Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Condition:   Pneumonia, Pneumococcal Intervention:   Biological: 23-Valent Pneumococcal Polysaccharide Vaccine Sponsor:   Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials